These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 15282667
21. Thrombin activatable fibrinolysis inhibitor in Behçet's disease. Donmez A, Aksu K, Celik HA, Keser G, Cagirgan S, Omay SB, Inal V, Aydin HH, Tombuloglu M, Doganavsargil E. Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188 [Abstract] [Full Text] [Related]
22. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis. Franco RF, Fagundes MG, Meijers JC, Reitsma PH, Lourenço D, Morelli V, Maffei FH, Ferrari IC, Piccinato CE, Silva WA, Zago MA. Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415 [Abstract] [Full Text] [Related]
23. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation. Chen CC, Lee KD, Gau JP, Yu YB, You JY, Lee SC, Hsu HC, Chau WK, Ho CH. Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424 [Abstract] [Full Text] [Related]
24. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Cruden NL, Graham C, Harding SA, Ludlam CA, Fox KA, Newby DE. Thromb Res; 2006 Oct; 118(2):189-97. PubMed ID: 16055173 [Abstract] [Full Text] [Related]
25. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease]. Xu CW, Wang LL, Wu XB, Zhao JJ, Du YM, Jiang CY. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146 [Abstract] [Full Text] [Related]
26. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis. Mosnier LO, Meijers JC, Bouma BN. Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322 [Abstract] [Full Text] [Related]
27. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis. Martini CH, Brandts A, de Bruijne EL, van Hylckama Vlieg A, Leebeek FW, Lisman T, Rosendaal FR. Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573 [Abstract] [Full Text] [Related]
28. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study. Sucker C, Hetzel GR, Farokhzad F, Dahhan F, Schmitz M, Kurschat C, Grabensee B, Maruhn-Debowski B, Zotz R, Scharf R. Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284 [Abstract] [Full Text] [Related]
31. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles. Boffa MB, Koschinsky ML. Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488 [Abstract] [Full Text] [Related]
32. Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation. Ladenvall C, Gils A, Jood K, Blomstrand C, Declerck PJ, Jern C. Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):955-62. PubMed ID: 17272741 [Abstract] [Full Text] [Related]
33. Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Karakurt F, Gumus II, Bavbek N, Kargili A, Koca C, Selcoki Y, Ozbek M, Kosar A, Akcay A. Gynecol Endocrinol; 2008 Sep; 24(9):491-7. PubMed ID: 18958767 [Abstract] [Full Text] [Related]
35. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease. Van Thiel DH, George M, Fareed J. Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503 [Abstract] [Full Text] [Related]
36. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Undén AL, Elofsson S, Brismar K. Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068 [Abstract] [Full Text] [Related]